[go: up one dir, main page]

DK2465493T3 - Topiske sammensætninger til forebyggelsen og behandlingen af irritation af mukøse celler - Google Patents

Topiske sammensætninger til forebyggelsen og behandlingen af irritation af mukøse celler

Info

Publication number
DK2465493T3
DK2465493T3 DK12159243.0T DK12159243T DK2465493T3 DK 2465493 T3 DK2465493 T3 DK 2465493T3 DK 12159243 T DK12159243 T DK 12159243T DK 2465493 T3 DK2465493 T3 DK 2465493T3
Authority
DK
Denmark
Prior art keywords
irritation
prevention
treatment
topical compositions
mucous cells
Prior art date
Application number
DK12159243.0T
Other languages
English (en)
Inventor
Shabtay Dikstein
Original Assignee
Resdevco Res And Dev Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36952425&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2465493(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Resdevco Res And Dev Co Ltd filed Critical Resdevco Res And Dev Co Ltd
Application granted granted Critical
Publication of DK2465493T3 publication Critical patent/DK2465493T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK12159243.0T 2005-05-16 2006-05-07 Topiske sammensætninger til forebyggelsen og behandlingen af irritation af mukøse celler DK2465493T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL168603A IL168603A (en) 2005-05-16 2005-05-16 Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells
EP06728329.1A EP1888024B2 (en) 2005-05-16 2006-05-07 Topical compositions

Publications (1)

Publication Number Publication Date
DK2465493T3 true DK2465493T3 (da) 2013-10-28

Family

ID=36952425

Family Applications (2)

Application Number Title Priority Date Filing Date
DK12159243.0T DK2465493T3 (da) 2005-05-16 2006-05-07 Topiske sammensætninger til forebyggelsen og behandlingen af irritation af mukøse celler
DK06728329.1T DK1888024T4 (da) 2005-05-16 2006-05-07 Topiske sammensætninger

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK06728329.1T DK1888024T4 (da) 2005-05-16 2006-05-07 Topiske sammensætninger

Country Status (8)

Country Link
US (2) US20080207771A1 (da)
EP (2) EP1888024B2 (da)
DK (2) DK2465493T3 (da)
ES (2) ES2393927T5 (da)
IL (1) IL168603A (da)
PL (2) PL1888024T3 (da)
PT (2) PT1888024E (da)
WO (1) WO2006123324A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10183076B2 (en) 2005-05-16 2019-01-22 Resdevco Research And Development Co. L Topical compositions for treatment of irritation of mucous membranes
US8679545B2 (en) * 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US9050368B2 (en) * 2007-11-13 2015-06-09 Meritage Pharma, Inc. Corticosteroid compositions
SI2211896T1 (en) 2007-11-13 2018-04-30 Meritage Pharma, Inc. Ingredients for the treatment of gastrointestinal inflammation
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
EP2363126A1 (en) * 2010-03-04 2011-09-07 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Composition comprising as active ingredient L-carnitine in combination with hydroxykynurenine-O-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
EP2667853A4 (en) 2011-01-25 2014-08-20 Procter & Gamble LIPOSOME AND BODY CARE COMPOSITION THEREWITH
IL212725A (en) 2011-05-05 2016-06-30 Resdevco Res And Dev Co Glycerol Preparation for Non-surgical Conjunctivochalysis
US9511144B2 (en) 2013-03-14 2016-12-06 The Proctor & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
JP2017503828A (ja) * 2014-01-28 2017-02-02 レスデブコ リサーチ アンド ディベロップメント カンパニー リミテッド 皮膚及び粘膜を局所処置するための、多価アルコール及びコレカルシフェロールを含む組成物
ITUB20153104A1 (it) * 2015-08-13 2017-02-13 Sooft Italia S P A Contrada Molino 17 68333 Montegiorgio Fm Composizione ed uso di collirio a base di inositolo per migliorare l'accomodazione visiva dei pazienti
JP7258778B2 (ja) 2017-03-05 2023-04-17 レスデブコ リサーチ アンド ディベロップメント カンパニー リミテッド 感染によるものではない刺激の治療のための点眼剤

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80298A (en) † 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
JPS63270625A (ja) * 1987-04-30 1988-11-08 Santen Pharmaceut Co Ltd 抗アレルギ−点眼剤
JPH0278619A (ja) * 1988-09-12 1990-03-19 Santen Pharmaceut Co Ltd 安定なピレノキシン点眼液
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
US5089255A (en) * 1989-06-26 1992-02-18 Colgate-Palmolive Company Dental remineralization
DE4229494A1 (de) * 1992-09-04 1994-03-10 Basotherm Gmbh Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks
DE4312656C2 (de) * 1993-04-19 1996-01-25 Beiersdorf Ag Kühlend wirkende kosmetische oder dermatologische Zusammensetzungen
GB9313329D0 (en) * 1993-06-28 1993-08-11 Scherer Ltd R P Softgel capsule shell compositions
TW274516B (da) * 1993-11-12 1996-04-21 Ciba Geigy Ag
US5866536A (en) * 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
PL208480B1 (pl) * 1997-03-20 2011-05-31 Schering Corp System dozujący
EP0909558A3 (en) * 1997-08-29 1999-10-27 Santen Pharmaceutical Co., Ltd. Chroman derivative containing ophthalmic solution
FI974385A0 (fi) † 1997-12-01 1997-12-01 Xyrofin Oy Anvaendning av xylitol foer bekaempning av jaestinfektion och xylitolpreparat foer denna anvaendning
US6238648B1 (en) † 1999-03-25 2001-05-29 The Procter & Gamble Company Anti-caries oral care compositions and their methods of use
GB9928055D0 (en) † 1999-11-26 2000-01-26 Alcan Int Ltd Oral cleansing product
US6361806B1 (en) * 2000-02-23 2002-03-26 Michael P. Allen Composition for and method of topical administration to effect changes in subcutaneous adipose tissue
US6716819B2 (en) * 2000-05-19 2004-04-06 University Of Iowa Research Foundation Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections
AR035509A1 (es) * 2000-12-21 2004-06-02 Alcon Inc Solucion de lagrimas artificiales mejorada que contiene una combinacion de tres emolientes y el uso de dicha solucion para la fabricacion de un medicamento
US20040044077A1 (en) * 2000-12-28 2004-03-04 Chika Katagiri Agents for inhibiting or restoring skin damage caused by drying and method for evaluating the same
JP4229422B2 (ja) 2001-07-04 2009-02-25 河野製紙株式会社 繊維ウェブ製品
ES2186569B1 (es) † 2001-09-28 2004-09-16 Lacer, S.A. Composiciones para el alivio de la xerostomia y el tratamiento de los trastornos asociados con la misma.
AU2002351402A1 (en) * 2001-12-18 2003-06-30 John Kanca Iii Device for dental applications
US6890961B2 (en) † 2002-02-01 2005-05-10 Micelle Products, Inc. Clear micellized formulations of β-carotene and method of treating leukoplakia
US6492379B1 (en) * 2002-02-21 2002-12-10 Super Gen, Inc. Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
AU2002325220A1 (en) * 2002-05-24 2003-12-12 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Drop-forming ophthalmic gel preparation comprising diclofenamide and timolol
US20040191332A1 (en) * 2003-03-27 2004-09-30 Allergan, Inc. Preserved ophthalmic compositions
JP3797431B2 (ja) † 2003-09-08 2006-07-19 ライオン株式会社 口腔用組成物及びその製造方法

Also Published As

Publication number Publication date
EP2465493B1 (en) 2013-08-07
DK1888024T3 (da) 2012-11-26
PL2465493T3 (pl) 2013-12-31
ES2393927T5 (es) 2015-12-21
US10660961B2 (en) 2020-05-26
US20170354735A1 (en) 2017-12-14
EP1888024B2 (en) 2015-07-15
PL1888024T3 (pl) 2013-02-28
US20080207771A1 (en) 2008-08-28
ES2393927T3 (es) 2013-01-02
ES2433271T3 (es) 2013-12-10
EP1888024A1 (en) 2008-02-20
IL168603A (en) 2011-05-31
DK1888024T4 (da) 2015-10-26
EP1888024B1 (en) 2012-08-29
EP2465493A1 (en) 2012-06-20
WO2006123324A1 (en) 2006-11-23
PT1888024E (pt) 2012-12-04
PT2465493E (pt) 2013-11-11

Similar Documents

Publication Publication Date Title
DK2465493T3 (da) Topiske sammensætninger til forebyggelsen og behandlingen af irritation af mukøse celler
DK1494692T3 (da) Topiske, farmaceutiske sammensætninger, der omfatter proanthocyanidiner, glycyrrhetinsyre og telmestein til behandlingen af dermatitis
DK1888033T3 (da) Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme
DK1644021T3 (da) Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
EP1727530A4 (en) TOPICAL FORMULATIONS FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS
ATE492272T1 (de) Therapeutische antimikrobielle zusammensetzungen und methoden
DK1896077T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af inflammatoriske sygdomme
DK2839830T3 (da) Kits og sammensætninger til behandling af lidelser i de nedre urinveje
DE602004027120D1 (de) Orale und/oder topische Zubereitungen
DK2063881T3 (da) Sammensætning og fremgangsmåde til virksom og sikker administration af halopyruvat til behandlingen af cancer
DK1771201T3 (da) Sammensætninger og fremgangsmåder til behandling eller forebyggelse af oxalat-relateret sygdom
DE602006021210D1 (de) Haarbehandlungszusammensetzungen
GB0817929D0 (en) Compositions for topical treatment
DK1765376T3 (da) Topiske sammensætninger og anvendelse deraf til behandling af epitel-relaterede tilstande
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
IL187405A0 (en) Methods and compositions for the treatment of pain
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
NO20070892L (no) Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse.
DK1644076T3 (da) Topisk sammensætning til behandling af akne og rosacea med galvanisk genereret elektricitet
DK1503747T3 (da) Diclofenacbaseret sammensætning til topisk behandling af sygdomme
EP1720563A4 (en) METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION
DK1882054T3 (da) Korrosionsbeskyttelsesanordning og fremgangsmåde
DK1812797T3 (da) Sammensætninger og fremgangsmåder til behandling og forebyggelse af hyperproliferative sygdomme
FI20040180L (fi) Koostumus psoriasis-taudin hoitamiseksi